Soc. Generale Knock-Out MRK/ DE000SF8RCV1 /
6/6/2024 9:38:32 PM | Chg.+0.05 | Bid10:00:43 PM | Ask10:00:43 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
5.42EUR | +0.93% | - Bid Size: - |
- Ask Size: - |
Merck and Co Inc | 71.7064 USD | 12/31/2078 | Call |
GlobeNewswire
6/6
Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
GlobeNewswire
5/28
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire
5/23
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire
5/16
Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
5/14
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire
5/8
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
4/24
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Onc...
GlobeNewswire
4/15
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
GlobeNewswire
4/9
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer...
GlobeNewswire
3/18
Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D...
GlobeNewswire
3/15
American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...